Allen & Overy (A&O) scored a 100 out of 100 on the 2023-2024 Corporate Equality Index (CEI) from the Human Rights Campaign (HRC), a political stakeholder group. By complying with the HRC’s controversial demands, Allen & Overy increases the risk of dividing employees, alienating customers and harming shareholders. The company provides a benefits package for employees which covers transgender medical procedures for covered employees and dependents, including children. It also uses sex and gender ideology criteria in employee recruitment, vendor selection, marketing, and philanthropic support. A&O forces employees to undergo multiple ideological trainings and uses its reputation, corporate funds, and political influence to support controversial sex and gender ideologies, organizations, and legislation. A&O does not publish a nondiscrimination policy. The company is recognized by Stonewall as a Top Global Employer for LGBTQ+ and implements unconscious bias training for its employees. The company has a reverse mentoring program and has hosted an LGBTQ+ initiative. A&O is Mansfield Certified, indicating its support of DEI in its recruitment, hiring, promotions, and leadership composition. The company is a partner of the Center for Reproductive Rights, building case law, advocating before policy makers, and engaging in litigation to challenge bans and restrictions on access to abortion. A&O is a member of the MCCA, indicating its focus on recruiting, retaining, and promoting employees based on race. The company is a part of the Law Firm Antiracism Alliance, committed to work on initiatives that fight “systemic racism”. For these reasons, A&O receives a High Risk rating.